14-10-2026 17:23 via drugs.com

EASD: Daily Orforglipron Pill Shows Comparable Cardiovascular Safety to Insulin Glargine

WEDNESDAY, Oct. 14, 2026-- The daily orforglipron pill has comparable cardiovascular safety to insulin glargine daily injections while providing additional benefits for adults with type 2 diabetes at increased cardiovascular risk, according to a...
Read more »

Pharmaceutical news



1990 to 2023 Saw Increase in Global Burden of Acne
Structured Support May Attenuate Weight Gain After GLP-1 RA Cessation
Universal Germline Testing IDs Hereditary Risk in Late-Onset Tumors
Obesity Linked to Lower Risk for Mortality in Dementia
Undeclared Pharmacologically Active Ingredients ID'd in OTC Skin Products
Trends in Catheter-Associated UTI Prevention Practices Examined Over Time
Recommendations Developed for Preventive Care in Cirrhosis
Longer Sleep Duration Linked to Progression of Diabetic Nephropathy
Late-Night Eating Linked to Increased Risk for MASLD, Cirrhosis
County-Level Variation Seen in Cardiovascular Disease Mortality
Online Sports Betting Linked To Rise In Depression And Anxiety Treatment
Man Pleads Guilty In $6 Million Medicare Scheme: How To Spot And Avoid These Scams
Step Up! How To Build A Walking Habit, 500 Steps At A Time
Lithium In Drinking Water Linked To Heart Birth Defect
Desktop versie